Two medtech firms among 12 new J&J Innovation Centers’ investments
This article was originally published in Clinica
Executive Summary
Johnson & Johnson's Innovation Centers are living up to their promise of supporting early-stage drug, device and consumer product development with 60 investments or partnerships under their collective belt to date, including 12 recently announced transactions.
You may also be interested in...
DePuy Synthes Builds Out Trauma Offering With TRS' 3D-Printed Tech
Underlining its focus on 3D-printing and the potential this technology can bring, DePuy Synthes has acquired the 3D-printed scaffold platform of Tissue Regeneration Systems, enabling the orthopedics leader to develop patient-specific trauma products in-house.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.